CELATOR PHARMACEUTICALS INC's ticker is CPXX and the CUSIP is 15089R102. A total of 123 filers reported holding CELATOR PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.44 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $273,000 | – | 9,025 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,232,272 | $67,370,000 | 76.00% |
| Avoro Capital Advisors LLC | 1,124,666 | $33,942,000 | 7.54% |
| FIRST NEW YORK SECURITIES LLC /NY | 252,691 | $7,626,214,000 | 4.69% |
| GLAZER CAPITAL, LLC | 965,785 | $29,147,000 | 3.76% |
| HARVEST MANAGEMENT LLC | 150,000 | $4,527,000 | 3.42% |
| LONGFELLOW INVESTMENT MANAGEMENT CO LLC | 290,000 | $8,752,000 | 3.11% |
| Sandell Asset Management Corp. | 448,293 | $13,529,000 | 3.00% |
| OMNI PARTNERS LLP | 7,293,750 | $7,294,000 | 2.71% |
| First Trust Capital Management L.P. | 240,598 | $7,261,248,000 | 2.67% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 649,249 | $19,594,000 | 2.55% |